Shimadzu partners with Abbott to integrate LC-MS automation with AlinIQ AMS lab informatics
Bitget2026/10/09 04:00Shimadzu started development, validation of an LC-MS automation solution with Abbott’s AlinIQ AMS at St. Vincent’s Hospital, Melbourne. Integration targets streamlined core-lab workflows, faster turnaround, improved reliability for clinical testing. Project uses Shimadzu’s CLAM-2040 CL sample-prep module, LCMS-8060 CL mass spectrometer, reagent kits linked to AlinIQ AMS. Move aligns with its June 4, 2026 plan to expand clinical diagnostics as a core growth driver via global partnerships. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shimadzu Corporation published the original content used to generate this news brief on October 09, 2026, and is solely responsible for the information contained therein.
- Shimadzu started development, validation of an LC-MS automation solution with Abbott’s AlinIQ AMS at St. Vincent’s Hospital, Melbourne.
- Integration targets streamlined core-lab workflows, faster turnaround, improved reliability for clinical testing.
- Project uses Shimadzu’s CLAM-2040 CL sample-prep module, LCMS-8060 CL mass spectrometer, reagent kits linked to AlinIQ AMS.
- Move aligns with its June 4, 2026 plan to expand clinical diagnostics as a core growth driver via global partnerships.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cathie Wood’s ARK Sells Bitcoin ETF, SpaceX and Robinhood Shares in Portfolio Shift
Analyst Gu Jingci: 10.10 Bitcoin/Ethereum Evening Trading Strategies and Market Analysis
Tekedia Capital flags signs global bond sell-off is losing momentum
Dogecoin ETF to Shut as Bitwise CEO Flags Weak Demand